BioCentury
ARTICLE | Clinical News

Alexion regulatory update

May 28, 1996 7:00 AM UTC

ALXN said notices of allowance were issued for three U.S. patents to third parties covering the company's xenotransplantation program. ALXN is exclusive licensee to the patents. ...